Key facts
- Akeso Biopharma (HKG: 09926) is a other based in Zhongshan, Guangdong.
About Akeso Biopharma (HKG: 09926)
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.
Free account
See the whole book
- ·Watchlist + alerts for Akeso Biopharma (HKG: 09926)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for Akeso Biopharma (HKG: 09926) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.